QCLS
$4.02
Post-MarketAs of Mar 17, 8:00 PM UTC
Q/C Technologies, Inc., a clinical-stage pharmaceutical company, focuses on developing and commercializing therapeutic platforms based on various therapeutic targets.
Historical Price
Price (Line)
Synthesizing Whystock Narrative...
Loading Financials...
Peer Comparison
AAPLMSFTGOOGL
Whystock Valuation Model
Calculated using a trailing P/E relative model adjusted by sector ROE and historical growth.
Current Price$4.02
Potential Upside
5%
Whystock Fair Value$4.22
Price
UndervaluedFair ValueOvervalued
Fundamentals
Q/C Technologies, Inc., a clinical-stage pharmaceutical company, focuses on developing and commercializing therapeutic platforms based on various therapeutic targets. The company develops Isomyosamine, a clinical stage small molecule that regulates t...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$31.57M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
2.23
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROIC
Average efficiency. Growth may require heavy reinvestment.
-40.63%
Quick Ratio
Pristine liquidity. Sufficient cash to cover all near-term obligations.
1.53
Recent News
No recent news found.